H

Herantis Pharma Oyj
OMXH:HRTIS

Watchlist Manager
Herantis Pharma Oyj
OMXH:HRTIS
Watchlist
Price: 1.445 EUR 1.05% Market Closed
Market Cap: 34.8m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of HRTIS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HRTIS Intrinsic Value
Not Available
H
Base Case Scenario

Fundamental Analysis

Herantis Pharma Oyj
OMXH:HRTIS
FI
Pharmaceuticals
Market Cap
34.8m EUR
IPO
Jun 11, 2014
FI
Pharmaceuticals
Market Cap
34.8m EUR
IPO
Jun 11, 2014
Price
€false
EPS
€false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HRTIS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Herantis Pharma Oyj
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Herantis Pharma Oyj

Current Assets 2.6m
Cash & Short-Term Investments 2.1m
Receivables 208.4k
Other Current Assets 228.6k
Efficiency

Free Cash Flow Analysis
Herantis Pharma Oyj

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Herantis Pharma Oyj

Revenue
0 EUR
Operating Expenses
-5m EUR
Operating Income
-5m EUR
Other Expenses
87.2k EUR
Net Income
-4.9m EUR
Fundamental Scores

HRTIS Profitability Score
Profitability Due Diligence

Herantis Pharma Oyj's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score

Herantis Pharma Oyj's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

HRTIS Solvency Score
Solvency Due Diligence

Herantis Pharma Oyj's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Positive Net Debt
Long-Term Solvency
47/100
Solvency
Score

Herantis Pharma Oyj's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HRTIS Price Targets Summary
Herantis Pharma Oyj

Wall Street analysts forecast HRTIS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HRTIS is 1.326 EUR with a low forecast of 0.707 EUR and a high forecast of 1.995 EUR.

Lowest
Price Target
0.707 EUR
51% Downside
Average
Price Target
1.326 EUR
8% Downside
Highest
Price Target
1.995 EUR
38% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Herantis Pharma Oyj
does not pay dividends
Shareholder Yield

Current shareholder yield for HRTIS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest